
Overview
John C. Rhee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Rhee is skilled in the management of all forms of cancer and blood diseases, with particular interest in cancers of the gastrointestinal tract and chest, including colorectal, esophageal, gastric, pancreaticobiliary, liver, neuroendocrine, and lung tumors.
Dr. Rhee is highly rated in 27 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Familial Pancreatic Cancer, Small Cell Lung Cancer (SCLC), Gamma Knife Radiosurgery, and Gastrostomy.
His clinical research consists of co-authoring 17 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5115 Centre Avenue, Hillman Cancer Center, Pittsburgh, PA 15232
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
UPMC Hillman Cancer Center
Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is highly rated in 42 conditions, according to our data. Her top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, Chondrosarcoma, and Gamma Knife Radiosurgery.
UPMC Hillman Cancer Center
Dan P. Zandberg, MD, is an associate professor of medicine and a medical oncologist/hematologist, specializing in the treatment of head and neck and thyroid cancers. He is the Director of the Head and Neck and Thyroid Cancer disease sections for the division of Hematology/Oncology and the Medical Oncology Co-Leader of the UPMC Hillman Head and Neck Cancer Program. He is also the physician lead for the second floor Hillman Cancer Center clinic. His main research focus is in the development of clinical trials with immunotherapy to improve patient outcomes. Recent awards include the 2019 National Cancer Institute (NCI) Cancer Clinical Investigator Team Leadership Award, 2020 Leo Criep, M.D. Excellence in Patient Care Award, and 2020/2021 Castle Connolly Regional Top Doctor. Dr. Zandberg is highly rated in 23 conditions, according to our data. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Oral Squamous Cell Carcinoma, Small Cell Lung Cancer (SCLC), and ALK-Positive Non-Small Cell Lung Cancer.
UPMC Hillman Cancer Center
Liza C. Villaruz, MD, is board-certified in medical oncology and hematology at UPMC Hillman Cancer Center, and she specializes in lung cancer and thoracic malignancies. Dr. Villaruz is highly rated in 13 conditions, according to our data. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC).
Frequently Asked Questions about Dr. John C. Rhee
How do I make an appointment with Dr. John C. Rhee?
You can book an appointment with Dr. John C. Rhee by calling their office at 412-946-2022. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. John C. Rhee a top-rated expert for Colorectal Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. John C. Rhee is classified as an Distinguished expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. John C. Rhee specialize in?
While Dr. John C. Rhee is a Hematology Oncology, they have specific expertise in Colorectal Cancer, Familial Pancreatic Cancer, and Small Cell Lung Cancer (SCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. John C. Rhee participate in research or clinical trials?
Yes. Dr. John C. Rhee has published 17 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Dr. John C. Rhee's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. John C. Rhee accept my insurance?
Dr. John C. Rhee accepts most major insurance plans, including Absolute Total Care South Carolina and Aetna. We recommend calling the office directly at 412-946-2022 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Colorectal CancerDr. Rhee isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Rhee isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Rhee isDistinguished. Learn about Familial Pancreatic Cancer.
- Lung CancerDr. Rhee isDistinguished. Learn about Lung Cancer.
- MesenchymomaDr. Rhee isDistinguished. Learn about Mesenchymoma.
- Pancreatic CancerDr. Rhee isDistinguished. Learn about Pancreatic Cancer.
- Advanced
- Adult Soft Tissue SarcomaDr. Rhee isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer
- Appendix CancerDr. Rhee isAdvanced. Learn about Appendix Cancer.
- Bone TumorDr. Rhee isAdvanced. Learn about Bone Tumor.
- Cholangiocarcinoma (Bile Duct Cancer)
- EGFR Positive Lung CancerDr. Rhee isAdvanced. Learn about EGFR Positive Lung Cancer.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Adenoid Cystic CarcinomaDr. Rhee isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adult Immune ThrombocytopeniaDr. Rhee isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Rhee isExperienced. Learn about Agranulocytosis.
- Alveolar Soft Part SarcomaDr. Rhee isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Ampullary CancerDr. Rhee isExperienced. Learn about Ampullary Cancer.



